Search by Medical Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Clinical Trials for Lipodystrophy, Congenital Generalized

• Efficacy and Safety of Mibavademab in Adult and Pediatric Patients With Generalized Lipodystrophy
• A Study of the Safety of Mibavademab in Pediatric and Adult Participants Switching From Metreleptin to Mibavademab for the Treatment of Generalized Lipodystrophy (GLD)
• Open-label Study to Evaluate Metreleptin in Children Under 6 Years of Age With Generalised Lipodystrophy
• A Extension Study of Empagliflozin in Patients With Refractory Diabetes Mellitus With Insulin Resistance ( EMPIRE-02 )
• Study of REGN4461, a Leptin Receptor Agonist Antibody, in Patients With Generalized Lipodystrophy
• Immunogenicity of Metreleptin in Patients With Generalized Lipodystrophy
• A Study of Empagliflozin in Patients With Refractory Diabetes Mellitus With Insulin Resistance
• Compassionate Use of Metreleptin in Previously Treated People With Generalized Lipodystrophy
• Trial of Leptin Replacement Therapy in Patients With Lipodystrophy